Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
INMB
|
James Kelly Ganjei
Director |
BUY
Grant, award, or other acquisition
|
Direct | 17,793 Added 50.0% |
$149,995
$8.43 p/Share
|
Mar 22
2022 |
|
INMB
|
David J Moss
Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct | 17,793 Added 1.42% |
$149,995
$8.43 p/Share
|
Mar 22
2022 |
|
INMB
|
Raymond Joseph Tesi
President and CEO |
BUY
Grant, award, or other acquisition
|
Direct | 23,724 Added 1.54% |
$199,993
$8.43 p/Share
|
Mar 22
2022 |
|
INMB
|
Mark William Lowdell
Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct | 23,590 Added 1.55% |
$198,864
$8.43 p/Share
|
Mar 22
2022 |
|
MIXT
|
Ian Jacobs
Director |
BUY
Open market or private purchase
|
Indirect | 3,170,375 Added 8.84% |
$1,521,780
$0.48 p/Share
|
Mar 22
2022 |
|
CECE
|
Richard F Wallman |
BUY
Open market or private purchase
|
Direct | 16,913 Added 14.36% |
$96,911
$5.73 p/Share
|
Mar 22
2022 |
|
XOMA
|
Thomas M. Burns
SVP, Finance & CFO |
SELL
Open market or private sale
|
Direct | 2,339 Reduced 26.3% |
$70,217
$30.02 p/Share
|
Mar 22
2022 |
|
XOMA
|
Thomas M. Burns
SVP, Finance & CFO |
BUY
Exercise of conversion of derivative security
|
Direct | 2,339 Added 20.82% |
$9,426
$4.03 p/Share
|
Mar 22
2022 |
|
XOMA
|
James R Neal
CEO |
SELL
Open market or private sale
|
Direct | 2,339 Reduced 16.52% |
$70,217
$30.02 p/Share
|
Mar 22
2022 |
|
XOMA
|
James R Neal
CEO |
BUY
Exercise of conversion of derivative security
|
Direct | 2,339 Added 14.18% |
$9,426
$4.03 p/Share
|
Mar 22
2022 |
|
RBOT
|
Philip Liang
Director |
SELL
Other acquisition or disposition
|
Indirect | 53,198 Reduced 2.58% |
-
|
Mar 22
2022 |
|
MITK
|
Michael E Diamond |
SELL
Open market or private sale
|
Direct | 3,696 Reduced 1.76% |
$52,483
$14.2 p/Share
|
Mar 22
2022 |
|
MITK
|
Stephen Ritter
Chief Technology Officer |
SELL
Open market or private sale
|
Direct | 2,840 Reduced 1.49% |
$40,328
$14.2 p/Share
|
Mar 22
2022 |
|
MITK
|
Scipio Maximus Carnecchia
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 9,957 Reduced 3.08% |
$141,389
$14.2 p/Share
|
Mar 22
2022 |
|
MITK
|
Jason Gray
GC, Secretary & Admin Officer |
SELL
Open market or private sale
|
Direct | 3,589 Reduced 2.93% |
$50,964
$14.2 p/Share
|
Mar 22
2022 |
|
BRG
|
Michael Di Franco
Executive VP, Operations |
BUY
Open market or private purchase
|
Direct | 1,000 Added 23.53% |
$26,610
$26.61 p/Share
|
Mar 22
2022 |
|
MCB
|
Mark R De Fazio
President and CEO |
SELL
Open market or private sale
|
Direct | 1,000 Reduced 1.0% |
$106,230
$106.23 p/Share
|
Mar 22
2022 |
|
SNCY
|
William Trousdale
Interim CFO and SVP |
SELL
Open market or private sale
|
Direct | 22,843 Reduced 100.0% |
$554,400
$24.27 p/Share
|
Mar 22
2022 |
|
SNCY
|
William Trousdale
Interim CFO and SVP |
BUY
Exercise of conversion of derivative security
|
Direct | 22,843 Added 50.0% |
$121,068
$5.3 p/Share
|
Mar 22
2022 |
|
MNRL
|
Pbra, LLC
Director |
SELL
Open market or private sale
|
Indirect | 802,298 Reduced 100.0% |
$19,255,152
$24.0 p/Share
|
Mar 22
2022 |
|
LADR
|
Pamela Mc Cormack
President |
SELL
Open market or private sale
|
Direct | 41,861 Reduced 5.27% |
$501,495
$11.98 p/Share
|
Mar 22
2022 |
|
GPI
|
Earl J Hesterberg
Retired |
SELL
Open market or private sale
|
Indirect | 6,706 Reduced 14.68% |
$1,313,303
$195.84 p/Share
|
Mar 22
2022 |
|
MORN
|
Joseph D Mansueto
Executive Chairman |
SELL
Open market or private sale
|
Direct | 9,337 Reduced 0.07% |
$2,643,678
$283.14 p/Share
|
Mar 22
2022 |
|
CRWD
|
Shawn Henry
CHIEF SECURITY OFFICER |
SELL
Open market or private sale
|
Direct | 35,652 Reduced 14.7% |
$7,591,737
$212.94 p/Share
|
Mar 22
2022 |
|
META
|
Jennifer Newstead
Chief Legal Officer |
SELL
Open market or private sale
|
Direct | 768 Reduced 4.76% |
$162,332
$211.37 p/Share
|
Mar 22
2022 |
|
BNFT
|
Indaba Capital Management, L.P.
Director |
BUY
Open market or private purchase
|
Indirect | 26,536 Added 0.69% |
$303,041
$11.42 p/Share
|
Mar 22
2022 |
|
FTCV
|
Luxor Capital Group, LP |
SELL
Open market or private sale
|
Indirect | 51,380 Reduced 1.47% |
$506,607
$9.86 p/Share
|
Mar 22
2022 |
|
PARR
|
Chai Trust CO LLC
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 21,885 Reduced 0.26% |
$267,216
$12.21 p/Share
|
Mar 22
2022 |
|
OSG
|
Cyrus Capital Partners, L.P.
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 203,770 Reduced 1.16% |
$434,030
$2.13 p/Share
|
Mar 22
2022 |
|
BMY
|
Giovanni Caforio
Executive Chair of the Board |
SELL
Bona fide gift
|
Direct | 420 Reduced 0.07% |
-
|
Mar 22
2022 |
|
PCVX
|
Grant Pickering
CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct | 7,712 Reduced 1.08% |
$189,869
$24.62 p/Share
|
Mar 22
2022 |
|
PCVX
|
Grant Pickering
CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct | 7,712 Added 1.07% |
$13,804
$1.79 p/Share
|
Mar 22
2022 |
|
DOMO
|
Catherine Wong
Chief Operating Officer |
SELL
Open market or private sale
|
Direct | 6,800 Reduced 4.07% |
$339,524
$49.93 p/Share
|
Mar 22
2022 |
|
FPI
|
Luca Fabbri
President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 2,647 Reduced 1.08% |
$35,232
$13.31 p/Share
|
Mar 22
2022 |
|
BDSI
|
Jeffrey Allen Bailey
Chief Executive Officer |
SELL
Other acquisition or disposition
|
Direct | 105,133 Reduced 100.0% |
-
|
Mar 22
2022 |
|
BDSI
|
Todd C Davis
Director |
SELL
Other acquisition or disposition
|
Direct | 252,207 Reduced 100.0% |
-
|
Mar 22
2022 |
|
BDSI
|
Peter Greenleaf
Director |
SELL
Other acquisition or disposition
|
Direct | 105,034 Reduced 100.0% |
-
|
Mar 22
2022 |
|
BDSI
|
Kevin Kotler
Director |
SELL
Other acquisition or disposition
|
Indirect | 7,588,395 Reduced 100.0% |
-
|
Mar 22
2022 |
|
BDSI
|
Scott M. Plesha
Officer |
SELL
Other acquisition or disposition
|
Direct | 345,127 Reduced 100.0% |
-
|
Mar 22
2022 |
|
BDSI
|
Mark A Sirgo
Director |
SELL
Other acquisition or disposition
|
Direct | 1,166,866 Reduced 100.0% |
-
|
Mar 22
2022 |
|
BDSI
|
Thomas B Smith
Chief Medical Officer |
SELL
Other acquisition or disposition
|
Direct | 52,530 Reduced 100.0% |
-
|
Mar 22
2022 |
|
BDSI
|
Vanila Singh
Director |
SELL
Other acquisition or disposition
|
Direct | 35,851 Reduced 100.0% |
-
|
Mar 22
2022 |
|
BDSI
|
W. Mark Watson
Director |
SELL
Other acquisition or disposition
|
Direct | 90,663 Reduced 100.0% |
-
|
Mar 22
2022 |
|
GRIL
|
Michael John Roper
Chief Governance & Compliance |
BUY
Open market or private purchase
|
Direct | 15,000 Added 11.11% |
$7,200
$0.48 p/Share
|
Mar 22
2022 |
|
CMTV
|
James G. Wheeler Jr. |
BUY
Open market or private purchase
|
Direct | 1,000 Added 26.53% |
$22,690
$22.69 p/Share
|
Mar 22
2022 |
|
IMRX
|
Scott Barrett
CHIEF MEDICAL OFFICER |
BUY
Open market or private purchase
|
Direct | 900 Added 10.63% |
$6,741
$7.49 p/Share
|
Mar 22
2022 |
|
MG
|
Dennis Bertolotti
President and CEO |
BUY
Grant, award, or other acquisition
|
Direct | 38,168 Added 7.53% |
-
|
Mar 22
2022 |
|
MG
|
Michael C Keefe
EVP, General Counsel |
BUY
Grant, award, or other acquisition
|
Direct | 7,666 Added 8.05% |
-
|
Mar 22
2022 |
|
MG
|
Michael J. Lange
Senior EVP |
BUY
Grant, award, or other acquisition
|
Direct | 6,840 Added 1.88% |
-
|
Mar 22
2022 |
|
MG
|
Edward J Prajzner
Sr. EVP and CFO |
BUY
Grant, award, or other acquisition
|
Direct | 12,214 Added 13.39% |
-
|
Mar 22
2022 |